Three years ago, the cigarette giant acquired Vectura, a British pharmaceutical firm that makes asthma inhalers, raising health groups’ ire. Now, it’s selling the business for almost $200 million.
The acting director of the Secret Service also cited “complacency” from others, as well as over-reliance on mobile devices and flaws in advance planning.